Building the business case for the introduction of APAS Independence
Introduction of automation into laboratories is a multi-faceted consideration requiring several stakeholders to inform decisions.
continue readingCase Study: Artificial Intelligence for Environmental Monitoring
This presentation discusses the application of artificial intelligence for environmental monitoring during pharmaceutical manufacturing. The APAS Independence is a laboratory automation device that uses advanced imaging and machine learning algorithms to interpret microbial growth on culture plates.
continue readingAutomated Reading of Agar Plates using AI
This presentation discusses the opportunity to improve environmental monitoring plate reading workflows at AstraZeneca through the use of artificial intelligence for automated reading of agar plates using APAS PharmaQC.
continue readingPreliminary performance testing of the APAS® Independence with APAS® PharmaQC artificial intelligence system for environmental monitoring in sterile manufacturing.
Microbiological methods remain deeply rooted in traditional practices and new technologies are being considered to improve the agility, accuracy, consistency, and data integrity within pharmaceutical laboratories.
continue readingData Integrity Challenges in the Pharmaceutical Microbiology Laboratory
A key foundation to Good Manufacturing Practice, is the execution and routine review of a robust environmental monitoring program. This takes the form of collecting environmental samples from surfaces, personnel and the cleanroom air, whether that be active or passive...
continue readingAPAS PharmaQC Pilot Secondary Validation Study Results
This study assessed the performance of the APAS Independence with PharmaQC analysis module to identify growth on TSA culture media. The study assessed the performance on 1,515 environmental monitoring plates collected at AstraZeneca’s manufacturing facility during routine production.
continue readingComparison of AI-assisted and manual zone interpretation of Nitroxoline in uncomplicated urinary tract infections.
Nitroxoline is one of the recommended first-line drugs for the treatment of uncomplicated urinary tract infections (uUTIs), but it is not included in the usual panels of automated susceptibility testing (AST) platform systems, such as MicroScan or Vitek.
continue readingDirect antimicrobial susceptibility testing for acute urinary tract infection – comparison of AI-assisted zone interpretation and conventional susceptibility testing methods.
Direct antimicrobial susceptibility testing (dAST) from urine samples using disc diffusion methods is in widespread use in some countries, allowing for the provision of results earlier than traditional AST methods, at a lower cost.
continue readingStreamlining Urine Processing with modular automation using DxM Autoplak and APAS Independence: A French experience with CPSE media
Investigation of urine samples remains a core focus for microbiology laboratories and has largely remained manual in nature.
continue readingEvaluation of the APAS Independence with Thermo Fisher Brilliance MRSA Analysis Module at NHS William Harvey Hospital
Screening of MRSA samples in routine microbiology is an important service to assist with infection control surveillance.
continue reading
